Razpipadon

N/A

Report date: 2026/03/12 20:00:16

NME

Base Information

Drug NameRazpipadon

Drug Alias NameCVL-871PF-06669571PF-6669571

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine D1 receptor agonistsDopamine D5 receptor agonists

TargetsDopamine D1 receptorDopamine D5 receptor

Therapy Area/IndicationsApathy in DementiaParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsApathy in DementiaParkinson Disease

ATC CodeN/A